Fedeli Ugo, Barbiellini Amidei Claudio, Han Xuesong, Jemal Ahmedin
Epidemiological Department, Azienda Zero, Veneto Region, Padova, Italy.
Surveillance & Health Equity Science Department, American Cancer Society, Atlanta, GA, USA.
J Natl Cancer Inst. 2024 Jan 10;116(1):167-169. doi: 10.1093/jnci/djad191.
Few studies have examined cancer-related mortality overall, never mind select cancer types, during the COVID-19 pandemic. Data on cancer-related mortality (any mention in death certificates, multiple causes of death approach) was extracted from the US Centers for Disease Control and Prevention WONDER database. Changes in trends for age-standardized mortality rates through 1999-2021 were assessed by Joinpoint analysis. In total, 1 379 643 cancer-related deaths were registered in 2020-2021, with cancer selected as the underlying cause in 88%. After 2 decades of decline, age-standardized cancer-related mortality increased from 2019 to 2021 for all cancers (annual percentage change = 1.6%, 95% confidence interval = 0.6% to 2.6%), especially for prostate cancer (annual percentage change = 5.1%, 95% confidence interval = 2.2% to 8.2%) and hematologic cancers (annual percentage change = 4.8%, 95% confidence interval = 3.1% to 6.6%). Sharp peaks in cancer-related deaths for many cancer sites were observed during pandemic waves in both 2020 and 2021, mostly attributed to COVID-19 as the underlying cause. Multiple causes of death analyses are warranted to fully assess the impact of the pandemic on cancer-related mortality.
在新冠疫情期间,很少有研究考察过总体癌症相关死亡率,更不用说特定癌症类型了。癌症相关死亡率数据(死亡证明中的任何提及,多死因方法)从美国疾病控制与预防中心的WONDER数据库中提取。通过Joinpoint分析评估了1999 - 2021年期间年龄标准化死亡率的趋势变化。2020 - 2021年共登记了1379643例癌症相关死亡,其中88%将癌症选为根本死因。经过20年的下降后,2019年至2021年所有癌症的年龄标准化癌症相关死亡率有所上升(年百分比变化 = 1.6%,95%置信区间 = 0.6%至2.6%),尤其是前列腺癌(年百分比变化 = 5.1%,95%置信区间 = 2.2%至8.2%)和血液系统癌症(年百分比变化 = 4.8%,95%置信区间 = 3.1%至6.6%)。在2020年和2021年的疫情高峰期间,许多癌症部位的癌症相关死亡出现了尖峰,主要归因于新冠病毒作为根本死因。有必要进行多死因分析,以全面评估疫情对癌症相关死亡率的影响。